AI주식인사이트AI Stock Insight
B

드림씨아이에스

223250KOSDAQ

62.0 / 100

Reference Date: 2026-10-23

Financial Score29.5 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Surged 32.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

DreamCIS is a Contract Research Organization (CRO) that provides comprehensive services such as clinical trial design, data management, statistical analysis, and regulatory submissions for pharmaceutical companies. With over 25 years of experience and global expansion, the company is addressing growing demand for high-value drug development, including gene therapies and next-generation treatments.

Number of Employees

395people

Average Salary

55.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
13.76Industry Average 15.005.0Point

In line with industry avg

PBR
1.18Industry Average 1.204.0Point

In line with industry avg

ROE
9.25Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
2.75Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲18.1% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲111.0% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 8.2% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (31%)

Current 4,115Won52-week high 7,69052-week low 2,450
1-month return6.0Point

1m +32.10% (strong rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0